StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

612

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

December 1, 2028

Study Completion Date

July 1, 2029

Conditions
Ischemic StrokeTransient Ischemic Attack
Interventions
DRUG

Statin (atorvastatin, fluvastatin, pravastatin, rosuvastatin or simvastatin)

"The intervention group receives statin treatment following the current Herseninfarct en Hersenbloeding guideline. The intensity and target value of statin treatment are determined according to this national guideline. Which statin (atorvastatin, fluvastatin, pravastatin, rosuvastatin, simvastatin) will be selected and what dose will be prescribed is left to the discretion of the treating neurologist. The statins are registered in the Netherlands and use will be according to the licenses of the products. They will be collected at the local pharmacy by the patient (following practice as usual)."

All Listed Sponsors
collaborator

VU University of Amsterdam

OTHER

lead

Prof. dr. Nathalie van der Velde

OTHER